Fulgent Genetics Stock News

Fulgent Genetics, Inc. (NASDAQ:FLGT) CFO Paul Kim sold 620 shares of Fulgent Genetics stock in a transaction that occurred on Thursday, December 2nd. The shares were sold at an average price of $83.16, for a total value of $51,559.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. []

SummerHaven Investment Management LLC acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,910 shares of the company’s stock, valued at approximately $981,000. Fulgent Genetics comprises approximately 0.6% of SummerHaven Investment Management LLC’s investment portfolio, […]

The genetic testing company's moat is expanding.

Fulgent Genetics, Inc. (NASDAQ:FLGT) was down 5% on Wednesday following insider selling activity. The company traded as low as $88.35 and last traded at $88.80. Approximately 2,827 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 1,083,843 shares. The stock had previously closed at $93.52. Specifically, CFO Paul []

The genetic testing company's moat is expanding.

Shares of these companies are gift-wrapped for those with patience.

GOLF, FLGT, GNK, CDEV, and ATCO have been added to the Zacks Rank #1 (Strong Buy) List on December 2nd.

GOLF, FLGT, GNK, CDEV, and ATCO have been added to the Zacks Rank #1 (Strong Buy) List on December 2nd.

Exchange Traded Concepts LLC trimmed its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) by 12.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 35,139 shares of the companys stock after selling 5,141 shares during the quarter. Exchange Traded Concepts LLC owned []

LA Sheriff Alex Villaneuva released a letter to the County Board of Supervisors contesting the use of Fulgent Genetics testing because of alleged ties to China.

Marshall Wace LLP lessened its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) by 88.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,823 shares of the companys stock after selling 49,955 shares during the period. Marshall Wace LLPs holdings in Fulgent []

Whether Fulgent is a value or a value trap depends on the short-term prospects for COVID-19 and the long-term prospects for its core sequencing business.

Fulgent Genetics (NASDAQ:FLGT) updated its FY 2021 earnings guidance on Tuesday. The company provided EPS guidance of $16.000-$16.000 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.240. The company issued revenue guidance of $930 million-$930 million, compared to the consensus revenue estimate of $948.20 million.Fulgent Genetics also updated its Q4 2021 []

Three Fool.com contributors are bullish on Beyond Air, Ocugen, and Fulgent Genetics.

Fulgent Genetics Inc. (NASDAQ:FLGT) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 3.23% to the previous days close as strong demand from buyers drove the stock to $89.40. Actively observing the price movement in the last trading, the stock closed the session at $86.60, falling within a range of $84.34 Fulgent Genetics Inc. (NASDAQ: FLGT) Forecast: Expect A -57.72% Drop Within A Few Months Read More »